BioSpace News Archive

Presentation to Highlight the Company’s Recent Progress on its Upcoming Acclaim-1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today the appointment of Dr. Tom Butera DVM, to the Company’s Board of Directors, effective December 1, 2020.

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced five projects selected to receive funding for clinical and preclinical evaluation of abemaciclib.

Ortho Regenerative Technologies Inc . (CSE: ORTH) (OTCQB: ORTIF) (" Ortho RTI " or the " Company "), an emerging orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today that it has completed a non-brokered private placement of secured non-convertible

Combination Offers Customers Access to Largest U.S. Oncology Real World Data Source and Best-in-Class Product Development Expertise for Faster, Smarter and More Patient-Centric Clinical Trials

Aidoc , the leading provider of enterprise AI solutions, and Imbio , a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality

For the fifth-consecutive season, the National Football League players will raise awareness for non-profit organizations and causes on the field through the My Cause My Cleats campaign, which allows players to utilize their platform by customizing their gameday cleats to raise funds through auctions of the cleats.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has provided $500,000 in scholarships to Lake Forest College and created a $500,000 Horizon Therapeutics Endowed Scholarship Fund at Howard University . The scholarships at both institutions will be awarded to economically disadvantaged students and students of color. “Equity in education is a significant global issue and we feel it is important for

New investors now have the opportunity to own a share of a variety of powerful robot technologies developed by 15 companies from Denmark, Israel, Norway, Poland, Spain, Sweden and Switzerland

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of David Wheadon, M.D.,